The government is now operating in accordance with the Guidance on Caretaker Conventions, pending the outcome of the 2025 federal election.

LAGEVRIO molnupiravir 200 mg capsules bottle (372650)

ARTG ID 372650

ARTG Name

LAGEVRIO molnupiravir 200 mg capsules bottle

Product name

LAGEVRIO molnupiravir 200 mg capsules bottle

ARTG Date

20 January 2022

Registration Type

Medicine

Therapeutic good type

Medicine

Ingredients

molnupiravir

Licence category

REP

Licence status

A

Summary

Product Information

Consumer Medicine Information

LAGEVRIO molnupiravir 200 mg capsules bottle, Merck Sharp Dohme Pty Ltd, CON-909

18 January 2022

Section 14 consent

Consent to while noncompliant with standards. The consent is effective for all batches released for supply from 18 January 2022 until 18 January 2024.
LAGEVRIO molnupiravir 200 mg capsules bottle, Merck Sharp & Dohme (Australia) Pty Ltd, CON-1182

17 November 2023

Section 14 consent

Consent to while noncompliant with standards. The consent is effective from 17 November 2023 until 29 February 2024.